Carbo Betulae D8/Crataegus D2 aa Injektionslösung (s.c.)

Country: Switzerland

Language: German

Source: Swissmedic (Swiss Agency for Therapeutic Products)

Active ingredient:

carbo betulae (HAB) D8 aquos. (Ph.Eur.Hom. 3.2.2), crataegus laevigata et crataegus monogyna e fructibus, ethanol. digestio D2 (Ph.Eur.Hom. 1.2.5)

Available from:

Weleda AG

INN (International Name):

carbo betulae (HAB) D8 aquos. (Ph.Eur.Hom. 3.2.2), crataegus laevigata et crataegus monogyna e fructibus, ethanol. digestio D2 (Ph.Eur.Hom. 1.2.5)

Pharmaceutical form:

Injektionslösung (s.c.)

Composition:

carbo betulae (HAB) D8 aquos. (Ph.Eur.Hom. 3.2.2) 500 mg, crataegus laevigata et crataegus monogyna e fructibus, ethanol. digestio D2 (Ph.Eur.Hom. 1.2.5) 500 mg, ethanolum 96 per centum, lactosum monohydricum, ethanolum 96 per centum, glucosum monohydricum, aqua ad iniectabile, pro vitro 1 ml, corresp. ethanolum 0.6 % V/V, corresp. ethanolum 0.6 % V/V.

Class:

B

Therapeutic group:

Anthroposophische Arzneimittel

Therapeutic area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

Authorization status:

zugelassen

Authorization date:

2013-01-30